Global Expansion Sebia's expansion in the United States and India creates access points to regional labs and hospital networks for MRD and multiple myeloma diagnostics, with opportunities to offer automated equipment and end-to-end workflow solutions.

Product Pipeline Robust test pipeline around multiple myeloma including MRD and anti-MCV assays positions Sebia to upsell integrated diagnostic panels to oncology centers and reference labs, complemented by workflow ready solutions.

Integrated Systems Leverage Sebia's emphasis on seamless lab workflows and traceability to offer data analytics, dashboards and laboratory information management system integrations that complement hardware deployments.

Strategic Partnerships Strategic collaborations with Janssen Biotech and Agilus Diagnostics indicate a ready made channel strategy; pursue co development and distribution agreements to accelerate market entry in new regions and lab networks.

Market Leadership Sebia's leadership in hemoglobinopathy and oncology diagnostics provides credibility to win large multi site contracts and network deals, supported by training and service packages that reduce total cost of ownership.